Merck denies offering $50 billion to buy Chinese herbal medicines

September 18, 2013 source: on September 17, Beijing News, a news appeared on the Internet titled "American companies offer 50 billion yuan for Chinese Herbal Prescriptions" After reprinted by people's network, various websites reprinted it According to the article, Merck, the US company, through a middleman, wants to buy a prescription of traditional Chinese medicine from "Anhui huaixia Institute of traditional Chinese medicine, the golden prescription of China" at a high price of RMB 50 billion Yesterday, Merck denied the incident to the Beijing News On September 3, Cui haolai, a Hong Kong businessman, on behalf of Merck, an American pharmaceutical giant headquartered in Darmstadt, Germany, wanted to buy a patent technology prescription for the treatment of liver cancer from huaixia Institute of traditional Chinese medicine in Anhui Province, the gold side of China, for 50 billion yuan, the news said According to the report, "after more than 30 years of scientific research, clinical practice and more than 60 million scientific research funds of two generations of Zhang's family of traditional Chinese medicine, the series of" super traditional Chinese medicine "programs have been successfully developed One of the technologies has obtained the national invention patent as early as 2001 At present, it has been reported that the Party Central Committee is applying for the Nobel Prize in medicine." "This is the unique technology in the world at present," said Chen Jianguo, an expert at the agency "It's only a joke to negotiate and buy this technology with a mere $50 billion!" The reporter noted that the description of "Merck, an American pharmaceutical giant headquartered in Darmstadt, Germany" in the news did not conform to the facts It is understood that Merck, headquartered in Darmstadt, Germany, is "German Merck", while "Merck, an American pharmaceutical giant", is "American Merck", headquartered in New Jersey, and "German Merck" is two different foreign pharmaceutical enterprises On September 17, the reporter called the headquarters of Merck China branch in Germany Qiu Ying, the head of the company's communication department, told the reporter that he had never heard of the company's purchase of traditional Chinese medicine prescriptions with RMB 50 billion "I don't know where the news source is The online news is not even accurate about the basic situation of the headquarters." "If this acquisition is a headquarters action, our Chinese company will get relevant information, but it has not," Qiu said Merck said in a public statement that Merck and any of its related subsidiaries do not know about "Cui haolai, a Hong Kong businessman" or "seeking for a patent technology prescription for liver cancer from huaixia Institute of traditional Chinese medicine, Anhui Province, the golden Party of China" This report does not represent any comments or views related to Merck / MSD's business The regulatory authorities "haven't heard" of the agency's "Anhui huaixia Research Institute of traditional Chinese medicine, the golden Party of China", which is the owner of the prescription mentioned in the news report The head of the office of the Anhui food and Drug Administration told the Beijing News yesterday, "haven't heard of the agency." Fan Kang, head of the information center of Huainan Health Bureau, told the Beijing news that the so-called Research Institute did not meet the registration requirements of the local health department and did not have the qualification to practice medicine Fan Kang said that he had refuted the news that the organization had overcome various human medical problems in some media several years ago "I dare say those are false." A reporter from the Beijing News found that there was no official website for the "huaixia Institute of traditional Chinese medicine, Anhui Province, China's Golden Square" Through the network, the reporter found the contact number shown as the organization When asked about Merck's $50 billion prescription purchase, Chen Jianguo, who called himself "Chen Jianguo" on the phone, said: "this is a matter of senior management of the group, I don't understand Zhang's family operates this business in some overseas and domestic companies "When the reporter asked about the group name, Chen Jianguo said," there are many groups, I can't tell you clearly " Chen Jianguo's title was "Professor of the expert committee of huaixia Institute of traditional Chinese medicine, Anhui Province, China's Golden Prescriptions", according to a report widely circulated on the Internet yesterday that "American companies are asking for 50 billion yuan to buy Chinese herbal prescriptions in China" As of the press release, the news about "American companies are asking for 50 billion yuan to buy traditional Chinese Medicine Prescriptions" is still spreading on the Internet Baidu's web page has more than 3000 identical search results CCTV and people's daily have both deleted the report But it's still being forwarded on Weibo ■ Zhang Zhengtian was questioned by netizens as a "liar" The reporter found that in addition to the "50 billion Prescriptions" reprinted on the Internet yesterday, there were many articles on the Internet about the academy and "Zhang Zhengtian, President of Chinese Academy of Medical Sciences, inventor of Chinese Super traditional medicine and honorary chairman of Anhui huaixia expert committee" The family report covers "success" in the treatment of psoriasis, rescue of liver cancer and leukemia According to Baidu Encyclopedia, "Zhang Zhengtian" also holds eight titles, including "chairman of China Golden medical expert consultation committee" and "chief expert of cancer research center of International Academy of Medical Sciences" At the same time, "he took the post of chairman of China News Online Committee in 2010." However, the reporter found that many netizens posted questions about Zhang Zhengtian as a liar A netizen asked, "is Zhang Zhengtian a man or a fairy? How can any disease be treated? " (Zhang Quanwei)